NYSE · HOSPITAL & MEDICAL SERVICE PLANS · LARGE CAP
Oscar Health, Inc. OSCR
7 fiscal years on record · USD · FY2025 reported
SEC FILINGS ONLY
Revenue · FY2025
$28.6M
▲ 39.0% vs FY2024
EPS · FY25
—
Dividend / sh · FY25
—
Payout · FY25
—
ROE · FY25
-44.5%
Net margin · FY25
-1549.9%
Dividend coverage
—
Advertisement
AdSense · Leaderboard 728×90320×100
Result
USD 28.6M
Revenue, FY2025 · full 7-year series below
Revenue
Net income
The company lost 1550 cents on every revenue dollar this year.
Per share
—
Diluted EPS, FY2025
EPS
The company pays no cash dividend.
Profitability
-44.5%
Return on equity, FY2025
ROE
Operating margin-1386.2%
Net margin-1549.9%
Return on assets-7.9%
Each USD of equity lost 45 cents this year.
Returned to shareholders
—
returned in FY2025 · dividends + net buybacks
Dividends paid—
Net buybacks—
Share of profit—
Consecutive raises—
Growth
—
revenue, compounded over five years
CAGR
3 yrs
5 yrs
10 yrs
15 yrs
Revenue
−23.9%
Compound annual rates per period — left blank where the series crosses a loss.
Share base
—
Shares outstanding, FY2025
Change, 5 years—
Change, 10 years—
A share split breaks the comparison across the period, so we leave it out.
Advertisement
AdSense · Leaderboard 728×90300×250
Balance sheet
USD 6.3B
total assets, end of FY2025
Total assetsUSD 6.3B
EquityUSD 977.6M
CashUSD 2.8B
Gross debtUSD 430.1M
Net debtUSD -2.3B
Current ratio0.95×
The company holds more cash than debt.
History
7 fiscal years
Every figure from documents filed with the SEC · USD
Metric
2025
2024
2023
2022
2021
2020
2019
Revenue $B
0.0
0.0
0.0
0.1
0.0
0.0
0.5
Operating income $B
−0.4
0.1
−0.2
−0.6
−0.5
−0.4
−0.3
EBITDA $B
−0.4
0.1
−0.2
−0.6
−0.5
−0.4
−0.3
Income tax $B
0.0
0.0
0.0
−0.0
0.0
0.0
0.0
Net income $B
−0.4
0.0
−0.3
−0.6
−0.6
−0.4
−0.3
EPS, diluted $
·
·
·
·
·
·
·
Dividend / sh $
·
·
·
·
·
·
·
Payout %
·
·
·
·
·
·
·
ROE %
−44.5
2.8
−32.0
−53.2
−1253.8
·
·
Shares out B
·
·
·
·
·
·
·
Slide the table for earlier years · "·" marks figures not disclosed in the filing for that year.
How we verifyAUDITED
19 of 19
checks passed before publication
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidity
Every figure was compared against the original statement: 0 failures and 0 presentation gaps.
What we don’t show
We’d rather say what’s missing than fill the gap with an estimate.
P/E rationeeds a market quote — not yet licensed
Market capitalizationneeds a market quote — not yet licensed
Dividend yieldneeds a market quote — not yet licensed
Price-to-bookneeds a market quote — not yet licensed